Trial intelligence / Profile preview

Intravenous magnesium sulfate to reduce anesthetic requirements during hysteroscopy

ChiCTR1900023497Phase 4Recruiting

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of magnesium sulfate in Endometrial diseases (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Propofol requirements and Fentanyl requirements. Started May 2019; status: recruiting.

02

Drugs

magnesium sulfate
03

Conditions

Endometrial diseases

Beyond the preview

Go deeper on ChiCTR1900023497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call